Naphazoline works by binding to the alpha-1 adrenoreceptors in the blood vessels. This binding leads to the release of noradrenaline, which also binds to the same receptors. After binding, the blood vessels constrict (vasoconstriction). As a result, less blood enters the affected region and the mucous membrane in the nose becomes less swollen. In the eyes, the lower blood volume means that fewer inflammatory substances reach the affected region, which reduces inflammation in the eye.
However, as naphazoline also binds to the beta-adrenoreceptors in a weakened form, the vessels dilate (vasodilation) after the alpha-1 adrenoreceptors have ceased to act, thus reversing the effect. Naphazoline therefore only relieves the symptoms of rhinitis and conjunctivitis, but does not combat the cause.
In addition, the release of noradrenaline causes negative feedback, i.e. reduced production of noradrenaline, which can lead to drug-induced inflammation of the nasal mucosa (rhinitis medicamentosa) if the nasal spray is used for too long. This leads to dependence and the naphazoline would need to be used every few hours to combat the swelling.
Naphazoline is broken down by the liver, but the majority is excreted unchanged in the urine. The effect of naphazoline can last for 4-8 hours.